{"id":6,"date":"2024-11-27T18:36:35","date_gmt":"2024-11-27T18:36:35","guid":{"rendered":"https:\/\/www.adarx.com\/?page_id=6"},"modified":"2026-09-09T09:41:31","modified_gmt":"2026-09-09T16:41:31","slug":"news","status":"publish","type":"page","link":"https:\/\/www.adarx.com\/dev\/news\/","title":{"rendered":"News"},"content":{"rendered":"\n

August 24, 2026<\/p>

ADARx Pharmaceuticals Receives FDA Fast Track Designation for Onvuzosiran for the Treatment of HAE<\/h3><\/a><\/div>

August 12, 2026<\/p>

ADARx Pharmaceuticals Expands Leadership Team with Board and Executive Appointments\u00a0<\/h3><\/a><\/div>

June 08, 2026<\/p>

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1\/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress<\/h3><\/a><\/div>

March 24, 2026<\/p>

ADARx Pharmaceuticals Expands Leadership Team with Appointment of Healthcare Investment Banking Veteran Ryan Fisk as Chief Financial Officer and Chief Business Officer<\/h3><\/a><\/div>

February 27, 2026<\/p>

ADARx Pharmaceuticals Presents Onvuzosiran Data Supporting Potential for Sustained Attack-Free Rates with Reduced Treatment Burden in Patients with HAE<\/h3><\/a><\/div>

February 20, 2026<\/p>

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1\/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting<\/h3><\/a><\/div>

February 05, 2026<\/p>

ADARx Pharmaceuticals Appoints Donald Fong, M.D., as Chief Medical Officer<\/h3><\/a><\/div>

December 02, 2025<\/p>

ADARx Pharmaceuticals Appoints Mary Tagliaferri, M.D., to its Board of Directors<\/h3><\/a><\/div>

November 07, 2025<\/p>

ADARx Pharmaceuticals Announces Positive Interim Phase 1 Clinical Data for its Novel siRNA Targeting Complement Factor B (CFB)<\/h3><\/a><\/div>

October 22, 2025<\/p>

ADARx Pharmaceuticals Announces First Patient Dosed in Phase 3 STOP-HAE Clinical Trial and Orphan Drug Designation for ADX-324, a Long-Acting siRNA in Development for the Prophylactic Treatment of Hereditary Angioedema (HAE)<\/h3><\/a><\/div>

October 20, 2025<\/p>

ADARx Pharmaceuticals Announces Clinical Data Presentation at the American Society of Nephrology (ASN) Kidney Week 2025<\/h3><\/a><\/div>

September 17, 2025<\/p>

ADARx Pharmaceuticals Appoints Industry Veteran, Laura Shawver, Ph.D., as Board Chair<\/h3><\/a><\/div>

September 04, 2025<\/p>

ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference<\/h3><\/a><\/div>

May 14, 2025<\/p>

AbbVie and ADARx Pharmaceuticals Announce Collaboration and License Option Agreement to Develop Next-Generation siRNA Therapies Across Multiple Therapeutic Areas<\/h3><\/a><\/div>

January 10, 2025<\/p>

ADARx Pharmaceuticals to Present at the J.P. Morgan 43rd Annual Healthcare Conference<\/h3><\/a><\/div>

July 30, 2024<\/p>

ADARx Pharmaceuticals Appoints Ajim Tamboli, CFA as Chief Financial Officer<\/h3><\/a><\/div>

February 21, 2024<\/p>

ADARx Pharmaceuticals to Participate in the 44th Annual Cowen Healthcare Conference<\/h3><\/a><\/div>

January 03, 2024<\/p>

ADARx Pharmaceuticals to Present at the J.P. Morgan 42nd Annual Healthcare Conference<\/h3><\/a><\/div>

August 09, 2023<\/p>

ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing<\/h3><\/a><\/div>

January 20, 2023<\/p>

ADARx Pharmaceuticals Announces Dosing of First Cohort in Phase 1 Clinical Study of ADX-324<\/h3><\/a><\/div>

January 20, 2023<\/p>

ADARx Pharmaceuticals Raises $46 Million as Lead Product Enters the Clinic<\/h3><\/a><\/div>

January 09, 2023<\/p>

ADARx Pharmaceuticals Expands Leadership Team, Appointing Robert MacLeod, Ph.D. as Chief Scientific Officer<\/h3><\/a><\/div>

June 07, 2022<\/p>

ADARx Pharmaceuticals Expands Leadership Team, Appointing Andrew Seacat as Head of Toxicology<\/h3><\/a><\/div>

January 25, 2022<\/p>

ADARx Pharmaceuticals Expands Leadership Team<\/h3><\/a><\/div>

September 08, 2021<\/p>

ADARx Raises $75 Million to Advance Growing Pipeline<\/h3><\/a><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":491,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-6","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nNews - ADARx Pharmaceuticals<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News - ADARx Pharmaceuticals\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adarx.com\/dev\/news\/\" \/>\n<meta property=\"og:site_name\" content=\"ADARx Pharmaceuticals\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-09T16:41:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.adarx.com\/dev\/dev\/wp-content\/uploads\/2024\/12\/news-header-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"891\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/news\\\/\",\"url\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/news\\\/\",\"name\":\"News - ADARx Pharmaceuticals\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/news\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/news\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/news-header-1.jpg\",\"datePublished\":\"2024-11-27T18:36:35+00:00\",\"dateModified\":\"2026-09-09T16:41:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/news\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.adarx.com\\\/dev\\\/news\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/news\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/news-header-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/wp-content\\\/uploads\\\/2024\\\/12\\\/news-header-1.jpg\",\"width\":2000,\"height\":891,\"caption\":\"news-header\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/news\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/#website\",\"url\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/\",\"name\":\"ADARx Pharmaceuticals\",\"description\":\"Providing hope for patients with intractable disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.adarx.com\\\/dev\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"News - ADARx Pharmaceuticals","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"News - ADARx Pharmaceuticals","og_url":"https:\/\/www.adarx.com\/dev\/news\/","og_site_name":"ADARx Pharmaceuticals","article_modified_time":"2026-09-09T16:41:31+00:00","og_image":[{"width":2000,"height":891,"url":"https:\/\/www.adarx.com\/dev\/dev\/wp-content\/uploads\/2024\/12\/news-header-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adarx.com\/dev\/news\/","url":"https:\/\/www.adarx.com\/dev\/news\/","name":"News - ADARx Pharmaceuticals","isPartOf":{"@id":"https:\/\/www.adarx.com\/dev\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.adarx.com\/dev\/news\/#primaryimage"},"image":{"@id":"https:\/\/www.adarx.com\/dev\/news\/#primaryimage"},"thumbnailUrl":"https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2024\/12\/news-header-1.jpg","datePublished":"2024-11-27T18:36:35+00:00","dateModified":"2026-09-09T16:41:31+00:00","breadcrumb":{"@id":"https:\/\/www.adarx.com\/dev\/news\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adarx.com\/dev\/news\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.adarx.com\/dev\/news\/#primaryimage","url":"https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2024\/12\/news-header-1.jpg","contentUrl":"https:\/\/www.adarx.com\/dev\/wp-content\/uploads\/2024\/12\/news-header-1.jpg","width":2000,"height":891,"caption":"news-header"},{"@type":"BreadcrumbList","@id":"https:\/\/www.adarx.com\/dev\/news\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.adarx.com\/dev\/"},{"@type":"ListItem","position":2,"name":"News"}]},{"@type":"WebSite","@id":"https:\/\/www.adarx.com\/dev\/#website","url":"https:\/\/www.adarx.com\/dev\/","name":"ADARx Pharmaceuticals","description":"Providing hope for patients with intractable disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adarx.com\/dev\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/pages\/6","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/comments?post=6"}],"version-history":[{"count":9,"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/pages\/6\/revisions"}],"predecessor-version":[{"id":1062,"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/pages\/6\/revisions\/1062"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/media\/491"}],"wp:attachment":[{"href":"https:\/\/www.adarx.com\/dev\/wp-json\/wp\/v2\/media?parent=6"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}